Iconovir Bio
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D, of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
8
11 to 50 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
3
tools in use
Monthly traffic
292
organic / mo
Sign up free to see all 5 verified contacts at Iconovir Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- PH
Pavla Hook
Senior Executive Assistant · General Business & Management
EmailPhone - AB
Angelica Becker
Senior Research Associate · Research & Development
EmailPhone - JH
John Huynh
Chief Technology Officer · Other
EmailPhone - MM
Mark McCamish
President and CEO · Other
EmailPhone - RQ
Robert Quesenberry
Clinical Development Operations Leader · Other
EmailPhone
Showing 5 of 5 verified contacts
Top roles at Iconovir Bio
5 distinct titles indexed · top 5 shown.
- 1chief technology officer
- 1clinical development operations leader
- 1president and ceo
- 1senior executive assistant
- 1senior research associate
Sign up to unlock all 5 contacts at Iconovir Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Iconovir Bio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.